Clin Res Cardiol (2021) DOI DOI https://doi.org/10.1007/s00392-021-01843-w |
||
The endothelial lncRNA NTRAS safeguards vascular integrity through regulating TJP1 isoform expression | ||
Y. Fouani1, L. Kirchhof1, L. Stanicek1, A. Heumuller1, G. Luxán1, A. Knau1, A. Fischer1, D. John1, P. Neumann1, K. Devraj2, R. Boon1, S. Liebner2, A. Bindereif3, I. Wittig4, C. Mogler5, M. Karimova6, S. Dimmeler1, N. Jaé1 | ||
1Zentrum für Molekulare Medizin, Institut für Kardiovaskuläre Regeneration, Goethe Universität Frankfurt am Main, Frankfurt am Main; 2Institute of Neurology (Edinger-Institute), Goethe Universität, Frankfurt; 3Institute of Biochemistry, Justus-Liebig-Universität Giessen, Gießen; 4Functional Proteomics, Goethe Universität, Frankfurt am Main; 5Institute of Pathology, Technische Universität München (TUM), Munich; 6Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Goethe Universität Frankfurt am Main, Frankfurt am Main; | ||
The semi-selective barrier provided by the endothelium ensures vascular integrity and tissue homeostasis. Under physiological conditions, interendothelial junction-complexes, including adherence and tight junctions, orchestrate vascular permeability in tissue-specific manner. In contrast, disintegration of these complexes is a hallmark of several detrimental pathologies including inflammation, oedema, and tissue ischemia. A huge endeavour has been made to understand the molecular mechanisms and pathways controlling endothelial barrier function; however, little is still known regarding the role of long non-coding RNAs in this context. Here we report on the endothelial-enriched lncRNA NTRAS as a gatekeeper of endothelial barrier function. In vivo, pharmacological Ntras silencing suffices to induce vascular leakage, demonstrated by increased extravasation of FTSC-dextran (123 ± 10%) and TMR-dextran (172 ± 27%) in murine heart tissue. Strikingly, Ntras-deficient mice showed a significantly reduced survival (-25% during 10 days follow up; p=0.01). Besides, ~60% of Ntras-silenced mice exhibited a broad range of cardiac pathologies, ranging from mild inflammation to severe defects such as myocarditis and scar formation (p<0.05). Mechanistically, we demonstrate NTRAS to interact with hnRNPL to fine-tune alternative splicing of tight junction protein 1 (TJP1) pre-mRNA, eventually regulating endothelial permeability. Specifically, by sequestration of the splicing regulator hnRNPL, NTRAS promotes the expression of the so-called TJP1a+ isoform which we found to contribute to endothelial resistance. In contrast, NTRAS silencing and targeted splicing modulation increase TJP1a- expression, and thereby impaired barrier function. Deleting a bona fide motif within Ntras, serving as a binding site for hnRNPL, impaired cardiac vascular integrity and manifested as induced tracer penetration (FTSC-dextran 147 ± 15%; TMR-dextran 163 ± 21%; p<0.05). At the same time, these mice showed induced cardiac inflammation characterized by an increased CD45+ cells infiltration (299 ± 34%; p<0.001) into heart tissue. Collectively, we unveil NTRAS as a constituent of a splicing-regulatory network detrimental in sustaining vascular integrity through preserving the equilibrium between TJP1α+ and α- isoforms. These results further expand our knowledge regarding the physiological roles of lncRNAs in vascular biology, especially in the context of regulating barrier function. |
||
https://dgk.org/kongress_programme/jt2021/aP1582.html |